# Xilio Development, INC. 401(k) Plan
Source: https://planprovider.pro/companies/xilio-development-inc-401k-plan

> Xilio Development, INC.'s 401(k) plan: 62 participants, plan year 2024 financials, providers, and benchmarks from Form 5500.

Form 5500 filing data for plan year 2024.

## Plan Snapshot

- **Plan Sponsor:** Xilio Development, INC.

- **Sponsor EIN:** 475489842

- **Sponsor Address:** 828 WINTER STREET, WALTHAM, MA, 02451

- **Plan Type:** 401(k)

- **Total Participants:** 62

- **Total Assets:** $9.8M

## Key Plan Design Features

- **Auto-Enrollment:** Yes

- **Auto-Escalation:** No

- **Allows Roth Contributions:** Yes

- **Participant Loans:** No

- **Participant-Directed Investments:** Yes

- **ERISA Section 404(c) Fiduciary Safe Harbor:** Yes

## Plan Financials by Year

| Year|Participants|Total Assets|Employer Contrib.|Employee Contrib.|

| 2024|62|$9.8M|$618,162|$1.3M|

| 2023|79|$7.8M|$862,546|$1.4M|

| 2022|98|$4.6M|$71,298|$1.3M|

## Similar Plans

- [Sigilon Therapeutics, INC.](https://planprovider.pro/companies/sigilon-therapeutics-inc-401k-plan) — 62 participants

- [Aktis Oncology, INC.](https://planprovider.pro/companies/aktis-oncology-inc-401k-plan) — 62 participants

- [Eic Laboratories, INC.](https://planprovider.pro/companies/eic-laboratories-inc-401k-plan) — 64 participants

- [Akili Interactive Labs, INC.](https://planprovider.pro/companies/akili-interactive-labs-inc-401k-plan) — 64 participants

- [Invaio Sciences, INC.](https://planprovider.pro/companies/invaio-sciences-inc-401k-plan) — 60 participants

- [Moma Therapeutics](https://planprovider.pro/companies/moma-therapeutics-401k-plan) — 59 participants

[View full interactive plan profile on PlanProvider.Pro](https://planprovider.pro/companies/xilio-development-inc-401k-plan)

© 2026 PlanProvider.Pro